MDWD
Income statement / Annual
Last year (2024), MediWound Ltd.'s total revenue was $20.22 M,
an increase of 8.22% from the previous year.
In 2024, MediWound Ltd.'s net income was -$30.22 M.
See MediWound Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$20.22 M |
$18.69 M |
$26.50 M |
$23.76 M |
$21.76 M |
$31.79 M |
$3.40 M |
$2.50 M |
$1.56 M |
$601.00 K |
| Cost of Revenue |
$18.44 M
|
$15.74 M
|
$14.18 M
|
$15.63 M
|
$14.75 M
|
$12.49 M
|
$2.19 M
|
$1.69 M
|
$2.27 M
|
$2.61 M
|
| Gross Profit |
$1.78 M
|
$2.95 M
|
$12.32 M
|
$8.14 M
|
$7.01 M
|
$19.30 M
|
$1.21 M
|
$808.00 K
|
-$712.00 K
|
-$2.00 M
|
| Gross Profit Ratio |
0.09
|
0.16
|
0.46
|
0.34
|
0.32
|
0.61
|
0.36
|
0.32
|
-0.46
|
-3.33
|
| Research and Development Expenses |
$8.25 M
|
$7.07 M
|
$9.61 M
|
$9.90 M
|
$7.35 M
|
$4.63 M
|
$4.02 M
|
$5.42 M
|
$7.04 M
|
$6.02 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.91 M
|
$11.38 M
|
$10.37 M
|
$9.45 M
|
$8.50 M
|
$9.01 M
|
$7.94 M
|
$9.08 M
|
$12.40 M
|
$13.21 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$21.16 M
|
$18.45 M
|
$19.98 M
|
$19.36 M
|
$15.85 M
|
$13.64 M
|
$11.96 M
|
$14.50 M
|
$19.44 M
|
$19.22 M
|
| Cost And Expenses |
$39.61 M
|
$34.19 M
|
$34.16 M
|
$34.98 M
|
$30.60 M
|
$26.12 M
|
$14.15 M
|
$16.18 M
|
$21.71 M
|
$21.83 M
|
| Interest Income |
$2.05 M
|
$2.34 M
|
$270.00 K
|
$11.00 K
|
$297.00 K
|
$434.00 K
|
$412.00 K
|
$349.00 K
|
$414.00 K
|
$288.00 K
|
| Interest Expense |
$561.00 K
|
$335.00 K
|
$162.00 K
|
$167.00 K
|
$200.00 K
|
$207.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$1.48 M
|
$1.30 M
|
$1.27 M
|
$1.24 M
|
$1.09 M
|
$1.15 M
|
$577.00 K
|
$567.00 K
|
$589.00 K
|
$503.00 K
|
| EBITDA |
-$28.12 M |
-$4.89 M |
-$18.09 M |
-$12.12 M |
-$7.99 M |
$3.42 M |
-$5.09 M |
-$13.97 M |
-$18.30 M |
-$21.17 M |
| EBITDA Ratio |
-1.39
|
-0.26
|
-0.68
|
-0.51
|
-0.37
|
0.11
|
-1.5
|
-5.6
|
-11.74
|
-35.22
|
| Operating Income Ratio |
-0.96
|
-0.83
|
-0.29
|
-0.47
|
-0.41
|
0.18
|
-3.16
|
-5.48
|
-12.94
|
-35.32
|
| Total Other Income/Expenses Net |
-$10.78 M
|
$8.97 M
|
-$11.86 M
|
-$2.30 M
|
-$436.00 K
|
-$3.60 M
|
$5.08 M
|
-$846.00 K
|
$1.27 M
|
-$444.00 K
|
| Income Before Tax |
-$30.16 M
|
-$6.53 M
|
-$19.52 M
|
-$13.52 M
|
-$9.28 M
|
$2.07 M
|
-$5.67 M
|
-$14.53 M
|
-$18.89 M
|
-$21.67 M
|
| Income Before Tax Ratio |
-1.49
|
-0.35
|
-0.74
|
-0.57
|
-0.43
|
0.06
|
-1.67
|
-5.82
|
-12.12
|
-36.06
|
| Income Tax Expense |
$61.00 K
|
$185.00 K
|
$78.00 K
|
$27.00 K
|
$0.00
|
$0.00
|
$0.00
|
$8.46 M
|
$0.00
|
$0.00
|
| Net Income |
-$30.22 M
|
-$6.72 M
|
-$19.60 M
|
-$13.55 M
|
-$9.20 M
|
$4.96 M
|
-$1.06 M
|
-$22.15 M
|
-$18.89 M
|
-$22.09 M
|
| Net Income Ratio |
-1.49
|
-0.36
|
-0.74
|
-0.57
|
-0.42
|
0.16
|
-0.31
|
-8.87
|
-12.12
|
-36.75
|
| EPS |
-3.03 |
-0.75 |
-3.93 |
-3.48 |
-2.38 |
1.26 |
-0.28 |
-6.64 |
-6.05 |
-7.13 |
| EPS Diluted |
-3.03 |
-0.75 |
-3.93 |
-3.48 |
-2.38 |
1.26 |
-0.28 |
-6.64 |
-6.05 |
-7.13 |
| Weighted Average Shares Out |
$9.96 M
|
$9.01 M
|
$4.99 M
|
$3.89 M
|
$3.89 M
|
$3.88 M
|
$3.87 M
|
$3.33 M
|
$3.12 M
|
$3.10 M
|
| Weighted Average Shares Out Diluted |
$9.96 M
|
$9.01 M
|
$4.99 M
|
$3.89 M
|
$3.89 M
|
$3.88 M
|
$3.87 M
|
$3.33 M
|
$3.12 M
|
$3.10 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
